Evidence map›Paper›PMID 40961494›Full record

Trial reportJournal of medical Internet research2025

Bridging Technology and Pretest Genetic Services: Quantitative Study of Chatbot Interaction Patterns, User Characteristics, and Genetic Testing Decisions.

Yang Yi, Lauren Kaiser-Jackson, Jemar R Bather, Melody S Goodman, Daniel Chavez-Yenter, Richard L Bradshaw, Rachelle Lorenz Chambers, Whitney F Espinel, Rachel Hess, Devin M Mann and 8 more

Abstract readPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. GARDE-Chat: a scalable, open-source platform for building and deploying health chatbots.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yang YiDepartment of Communication, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0001-6178-0758
Lauren Kaiser-JacksonHuntsman Cancer Institute, Salt Lake City, UT, United States.ORCID https://orcid.org/0009-0002-6623-7126
Jemar R BatherCenter for Anti-Racism, Social Justice & Public Health, School of Global Public Health, New York University, New York, United States.ORCID https://orcid.org/0000-0002-0285-3678
Melody S GoodmanCenter for Anti-Racism, Social Justice & Public Health, School of Global Public Health, New York University, New York, United States.ORCID https://orcid.org/0000-0001-8932-624X
Daniel Chavez-YenterDivision of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.ORCID https://orcid.org/0000-0001-7764-4443
Richard L BradshawDepartment of Biomedical Informatics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0001-7363-0327
Rachelle Lorenz ChambersPerlmutter Cancer Center, NYU Langone Health, New York, NY, United States.ORCID https://orcid.org/0000-0003-2478-8835
Whitney F EspinelHuntsman Cancer Institute, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0002-7159-9239
Rachel HessDepartment of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-2545-8504
Devin M MannDepartment of Population Health, NYU Grossman School of Medicine, New York City, NY, United States.ORCID https://orcid.org/0000-0002-2099-0852
Rachel MonahanPerlmutter Cancer Center, NYU Langone Health, New York, NY, United States.ORCID https://orcid.org/0000-0003-1000-2790
David W WetterDepartment of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0002-4013-1932
Ophira GinsburgCenter for Global Health, National Cancer Institute, Rockville, MD, United States.ORCID https://orcid.org/0000-0002-1384-2675
Meenakshi SigireddiPerlmutter Cancer Center, NYU Langone Health, New York, NY, United States.ORCID https://orcid.org/0000-0003-4448-0504
Kensaku KawamotoDepartment of Biomedical Informatics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-4282-9338
Guilherme Del FiolDepartment of Biomedical Informatics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0001-9954-6799
Saundra S BuysHuntsman Cancer Institute, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-4120-5697
Kimberly A KaphingstDepartment of Communication, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-2668-9080

Funding

Leveraging an electronic medical record infrastructure to identify primary care patients eligible for genetic testing for hereditary cancer and evaluate novel cancer genetics service delivery modelsU01CA232826 · NCI · UNIVERSITY OF UTAH · PI KAPHINGST, KIMBERLY A, SIGIREDDI, MEENAKSHI · 2018 to 2022
$5.5M
GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk ManagementU24CA274582 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI GUILHERME DEL FIOL, Kensaku Kawamoto · 2023 to 2026
$3.3M
NCI NIH HHS U01 CA232826NCI NIH HHS U24 CA274582
6 · The paper itself

Abstract

backgroundAmong the alternative solutions being tested to improve access to genetic services, chatbots (or conversational agents) are being increasingly used for service delivery. Despite the growing number of studies on the accessibility and feasibility of chatbot genetic service delivery, limited attention has been paid to user interactions with chatbots in a real-world health care context.

objectiveWe examined users' interaction patterns with a pretest cancer genetics education chatbot as well as the associations between users' clinical and sociodemographic characteristics, chatbot interaction patterns, and genetic testing decisions.

methodsWe analyzed data from the experimental arm of Broadening the Reach, Impact, and Delivery of Genetic Services, a multisite genetic services pragmatic trial in which participants eligible for hereditary cancer genetic testing based on family history were randomized to receive a chatbot intervention or standard care. In the experimental chatbot arm, participants were offered access to core educational content delivered by the chatbot with the option to select up to 9 supplementary informational prompts and ask open-ended questions. We computed descriptive statistics for the following interaction patterns: prompt selections, open-ended questions, completion status, dropout points, and postchat decisions regarding genetic testing. Logistic regression models were used to examine the relationships between clinical and sociodemographic factors and chatbot interaction variables, examining how these factors affected genetic testing decisions.

resultsOf the 468 participants who initiated a chat, 391 (83.5%) completed it, with 315 (80.6%) of the completers expressing a willingness to pursue genetic testing. Of the 391 completers, 336 (85.9%) selected at least one informational prompt, 41 (10.5%) asked open-ended questions, and 3 (0.8%) opted for extra examples of risk information. Of the 77 noncompleters, 57 (74%) dropped out before accessing any informational content. Interaction patterns were not associated with clinical and sociodemographic factors except for prompt selection (varied by study site) and completion status (varied by family cancer history type). Participants who selected ≥3 prompts (odds ratio 0.33, 95% CI 0.12-0.91; P=.03) or asked open-ended questions (odds ratio 0.46, 95% CI 0.22-0.96; P=.04) were less likely to opt for genetic testing.

conclusionsFindings highlight the chatbot's effectiveness in engaging users and its high acceptability, with most participants completing the chat, opting for additional information, and showing a high willingness to pursue genetic testing. Sociodemographic factors were not associated with interaction patterns, potentially indicating the chatbot's scalability across diverse populations provided they have internet access. Future efforts should address the concerns of users with high information needs and integrate them into chatbot design to better support informed genetic decision-making.

Indexed as

Generative Artificial IntelligenceGenetic ServicesGenetic TestingAdultDecision MakingFemaleHumansMaleMiddle Agedcancer geneticschatbot deliverygenetic testingpretest genetic servicesuser interaction

Identifiers

PMID40961494
PMCPMC12489413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.